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SUMMARY
The presence of serological markers for hepatitis B virus (HBsAg, anti-HBc IgM and Anti-HBc total) was investigated in the
serum of 1,396 individuals who had clinical suspect of hepatitis. It was observed that 50.7% of the individuals were positive and, from
the total of the studied individuals, 14.5% were positive for HBsAg. From these, 8.5% were also positive for anti-HBc IgM. The
analysis in relation to gender showed a higher seroprevalence index among male individuals (p < 0.0001). It was observed the
occurrence of subtypes adw2 (62.7%), ayw3 (23.5%), ayw2 (9.8%) and adw4 (3.9%). The viral DNA was detected in 61 (33.9%)
HBsAg positive samples and in one sample positive only for anti-HBc total. These results indicate an important incidence of the HBV
infection in this population, and reinforce previous studies regarding this virus in the central west region of Brazil.
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INTRODUCTION
The hepatitis B virus (HBV) is disseminated throughout the human
population and it is estimated that there are over 350 million chronic
carriers of the virus, which represents approximately 5% of the world
population22. The virus may cause in the host both asymptomatic and
symptomatic infection and the disease might evolve to cirrhosis and
hepatocelular carcinoma24,33. The HBV presents genetic variability that
is demonstrated by the occurrence of subtypes and genotypes which
present different distribution in relation to the geographical area2,12,23.
Several investigations have been made regarding HBV aiming at the
characterization of the positive samples for the virus, since this procedure
is also useful in the comprehension of the development of the
infection21,42.
In Goiânia-Goiás, studies about HBV seroprevalence have been
developed and the important spreading of the agent in this region has
been demonstrated3,4,6,7,32,39. However, there is no data regarding this virus
in population that presents clinical suspect of hepatitis. This study aims
at the detection of serological markers for HBV and the viral DNA, as
well as the determination of HBV subtypes in this population group.
MATERIAL AND METHODS
Studied population: From August 1995 to July 1997, 1,396 blood
samples were obtained from equal number of patients with clinical
evidence of hepatitis which attended the health public system of Goiânia-
GO. The clinical suspect of hepatitis included at least one of the following
characteristics (linked epidemiological data): low fever, jaundice, gastric
intestinal symptoms (nausea and vomit) and elevations of serum
aminotransferase activities. From this population, 897 were male and
499 female.
METHODOLOGY
1 - Detection of serological markers for HBV: The 1,396 blood
samples were tested aiming at the detection of hepatitis B surface antigen
(HBsAg), IgM antibodies to hepatitis B core antigen (anti-HBc IgM)
and total antibodies to hepatitis B core antigen (anti-HBc total). For this
procedure enzyme immunoassay (EIE) commercial kits were used
(Hepanostika-Organon Teknika B.V., Boxtel, Netherlands). The assays
were performed as described by the manufacturers.
2 - Subtyping of the HBsAg positive samples: The HBsAg positive
samples were titled by reverse passive hemaglutination (Biomanguinhos/
Fiocruz/Rio de Janeiro/Brazil) and the samples that presented a title equal
or higher than 28 hemaglutination units were subtyped by radial
immunodiffusion. The samples that presented a title between 24 and 28
units were analyzed by EIE with monoclonal antibodies. All
immunobiologicals used in both assays were prepared and supplied by
the Center of National Reference in Viral Hepatitis/Oswaldo Cruz
Foundation/Rio de Janeiro-RJ/Brazil.
3 - DNA detection: The HBsAg positive samples were tested by
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two methodologies for detection of viral DNA: 85 were tested by
molecular hybridization (Dot-blot) and 95 by polymerase chain reaction
(PCR). Moreover, 28 positive samples for Anti-HBc total and negative
for HBsAg were also tested by PCR. The methodology of Dot-blot was
performed in agreement with NIEL et al. (1994)28 with modifications.
The probe was labelled with [32P] dATP using the kit Megaprime DNA
labeling system RPN 1604 (Amershan Biosciences, Buckinghamshire,
UK).
For the PCR procedure, the DNA was extracted from serum samples
and amplified according to description of NIEL et al. (1994)28. First, the
samples were tested using 5 pairs of primers for the conserved areas of
genome (PS1-PS2, X1-X2, C1-C2, C1-PS2 and PS1-S2). The negative
samples in this first stage, were then submitted to the semi-nested PCR,
using the pairs of primers PS1-PS2 and PS4-S215,28. The PCR procedure
utilized is able to detect 100 copies per genome (Gomes, S.A. – personal
communication).
RESULTS
1 - Seroprevalence: It was observed a seroprevalence index of 50.7%
(HBsAg/anti-HBc IgM; HBsAg/anti-HBc total; anti-HBc total). From
the total of 1,396 individuals, 14.5% were positive for HBsAg and 8.5%
were also positive to anti-HBc IgM (Table 1). Moreover, from the 897
male individuals, 60.1% were positive in relation to 33.9% of the female
individuals (p < 0.0001) (Table 2).
2 - Subtyping: From the subtyped samples, 32 (62.7%) were adw2,
12 (23.5%) ayw3 and the remaining samples were ayw2 (9.8%) and adw4
(3.9%). The analysis in relation to the year shows that the subtype adw2
occurred throughout the years of study, while the subtypes ayw3 and
adw4 occurred only during the year of 1996 and the ayw2 in 1995 and in
1996 (Table 3).
3 - Detection of viral DNA: Positivity indexes of 35.3% and 32.6%
were observed for viral DNA using the methodologies of Dot-blot and
PCR respectively (Table 4). From the 28 negative serum samples for
HBsAg and positive for anti-HBc total, one was positive for viral DNA.
It was also observed that the pair C1-C2 presented the highest index
(21.6%) of detection of the viral DNA followed by X1-X2 (12.6%) and
PS1-PS2 (11.6%).
DISCUSSION
Although there are many epidemiological surveys regarding HBV
seroprevalence reported in literature, the occurrence of HBV in clinical
cases of hepatitis has been poorly documented. In this way, few studies
have been carried out with population similar to this study. In a study by
CASEY et al. (1996)9 performed in Peru, a seroprevalence index of 100%
was observed. In the present study, a global index of 50.7% of HBV
seropositivity was detected. Comparing this result with data from the
literature, concerning other population, it was observed that this index
is higher than several other indexes detected in different parts of the
world1,8,13,20, including Goiânia-Goiás3,6,32.
The analysis of the distribution of the serological markers for HBV
shows that 14.5% of the individuals were positive for HBsAg and 8.5%
were also positive for anti-HBc IgM, which indicates not only the
condition of carriers of the virus, but also acute infection. These indexes
were higher when compared to studies accomplished in different areas
of the world with populations different from this study20,37,40, the same
occurring in Brazil30,36, including Goiânia-Goiás4,34,39. Also, it was
Table 4
Detection of HBV-DNA by Dot-blot and PCR methodologies, in relation to
the serological markers, in individuals with clinical evidence of hepatitis from
Goiânia-Goiás
Dot-blot PCR
N (%) N (%)
HBsAg/anti-HBc IgM 19/42 (45.2) 19/64 (29.7)
HBsAg/anti-HBc total 11/43 (25.6) 12/31 (38.7)
Total 30/85 (35.3) 31/95 (32.6)
N - number of positive samples/ number of tested samples
Table 3
Distribution of HBsAg subtypes from 51 hepatitis B virus positive samples
obtained from individuals of Goiânia-Goiás in relation to the year of
collection
Year adw2 ayw3 ayw2 adw4 Total
1995 10 - 01 - 11
1996 11 12 04 02 29
1997 11 - - -  11
Total 32 12 05 02  51
(62.7%) (23.5%) (9.8%) (3.9%) (100.0%)
Table 1
Distribution of hepatitis B virus positive serum samples, obtained from
individuals with clinical evidence of hepatitis, in relation to the serological
markers
N %*
HBsAg/ anti-HBc IgM 119 8.5
HBsAg/ anti-HBc total 83 6.0
Anti-HBc total 506 36.2
Total 708 50.7
*Index calculated in relation to the 1,396 blood samples analyzed; N- number of
positive samples.
Table 2
Distribution of hepatitis B virus positive samples obtained from individuals
with clinical evidence of hepatitis, in relation to the gender
Positives/Total %
Male* 539/897 60.1
Female 169/499 33.9
Total 708/1396 50.7
*X2 = 88.2 p < 0.0001
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observed that other studies accomplished with similar population
presented higher HBsAg indexes of detection, such as 59.3% in patients
with hepatocarcinoma in Nigeria31, 60.0% in patients with acute hepatitis
in Somalia29 and 88.0% in military recruits from Peru9.
The data showed higher detection of HBV (60.1%) among male
individuals, which was also demonstrated by other studies1,26.
In this study it was observed a predominance of the subtype adw2
followed by ayw3, which is in agreement with other studies14,39, and
supports previous results that have demonstrated a higher prevalence of
these subtypes during the last decade in the region of Goiânia, Goiás,
Brazil14.
Indexes of viral DNA detection of 35.3% and 32.6% were observed
by Dot-blot and PCR, respectively. These results are in agreement with
the studies accomplished by TEDESCHI et al. (1989)38 and
CHIARAMONTE et al. (1991)11 although they differ from other studies
in which it has been observed higher indexes of detection for HBV-
DNA by PCR2,16,27 and Dot-blot26.
A higher detection of the viral DNA was observed when the C1-C2
primer pair was used, and this fact is in agreement with previous study15.
Although some studies have been observed the occurrence of mutations
in the genomic area Pre-C/C21,43, it is assumed that it is a conserved
genomic area17 and, in this way, the present study confirmed the
effectiveness of this pair of primers for HBV-DNA detection.
From the 28 anti-HBc total positive samples tested by PCR, one was
positive. Some reports have shown the detection of the HBV-DNA by
PCR in individuals positive for anti-HBc total/ anti-HBs, and even in
individuals without any serological marker for the infection15,35,41 and
some explanations have been proposed to elucidate this condition5,18,19,43.
In any case, this fact supports the importance of screening by anti-HBc
at the blood banks from all areas of the world and point out the
requirement of improving the screening methods used for viral
detection10,15,25,35.
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RESUMO
Soroprevalência da infecção pelo vírus da hepatite B em
indivíduos com evidência clínica de hepatite em Goiânia, Goiás.
Detecção do DNA viral e determinação dos subtipos
Investigou-se a presença dos marcadores sorológicos AgHBs, anti-
HBc IgM e anti-HBc total no soro de 1.396 indivíduos com suspeita
clínica de hepatite. Observou-se uma soroprevalência para a infecção
pelo VHB de 50,7%, sendo que do total dos 1.396 indivíduos, 14,5%
eram positivos para AgHBs e 8,5% eram também positivos para anti-
HBc IgM, tendo ainda sido observado que a soroprevalência foi maior
em indivíduos do sexo masculino (p < 0,0001). Por subtipagem foram
identificados os seguintes subtipos: adw2 (62,7%), ayw3 (23,5%), ayw2
(9,8%) e adw4 (3,9%). O DNA viral foi detectado em 61 (33,9%) amostras
positivas para o AgHBs e em uma amostra positiva somente para anti-
HBc total. Estes resultados indicam importante índice de ocorrência da
infecção pelo VHB nesta população e reforça dados de estudos anteriores
a respeito da importante circulação do vírus na região Centro-Oeste do
Brasil.
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